BioCardia (BCDA) Depreciation & Amortization (CF) (2010 - 2026)
BioCardia's (BCDA) quarterly Depreciation & Amortization (CF) came in at $3000.0 in Q2 2026, down 40.0% year-over-year from $5000.0 in Q2 2025, and little changed quarter-over-quarter from $3000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Depreciation & Amortization (CF) for 12 consecutive years, with $3000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 40.0% year-over-year to $3000.0 in Q2 2026; TTM through Jun 2026 was $13000.0, a 72.92% decrease from a year earlier, with the FY2025 full-year figure at $24000.0, down 64.18% from the prior year.
- Depreciation & Amortization (CF) was $3000.0 for Q2 2026 at BioCardia, roughly flat from $3000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $29000.0 in Q3 2022 and troughed at $3000.0 in Q4 2025.
- A 5-year average of $14611.1 and a median of $16000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) jumped 93.33% in 2022 and slumped 80.0% in 2025, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $21000.0 in 2022, then retreated by 4.76% to $20000.0 in 2023, then declined by 25.0% to $15000.0 in 2024, then tumbled by 80.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3000.0 (Q2 2026), $3000.0 (Q1 2026), and $3000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 4.28 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 3.78 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 4.00 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 4.91 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 5.41 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 1.10 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 10.41 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 3.62 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 15,000.00 |